[go: up one dir, main page]

Messenger et al., 2012 - Google Patents

Developments in the assessment of venous invasion in colorectal cancer: implications for future practice and patient outcome

Messenger et al., 2012

Document ID
8237326792711681916
Author
Messenger D
Driman D
Kirsch R
Publication year
Publication venue
Human pathology

External Links

Snippet

Venous invasion, or “large vessel” invasion, is a known independent prognostic indicator of distant recurrence and survival in colorectal cancer. Accurate assessment of venous invasion is of particular importance in stage II disease because it may influence the decision …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F9/00—Arrangements for programme control, e.g. control unit
    • G06F9/06—Arrangements for programme control, e.g. control unit using stored programme, i.e. using internal store of processing equipment to receive and retain programme
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data

Similar Documents

Publication Publication Date Title
Messenger et al. Developments in the assessment of venous invasion in colorectal cancer: implications for future practice and patient outcome
Dong et al. Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer
Calderaro et al. ESM1 as a marker of macrotrabecular-massive hepatocellular carcinoma
Kirsch et al. Venous invasion in colorectal cancer: impact of an elastin stain on detection and interobserver agreement among gastrointestinal and nongastrointestinal pathologists
Lin et al. Urinary TMPRSS2: ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study
Rummel et al. Tumour location within the breast: Does tumour site have prognostic ability?
Wang et al. Clinicopathological significance of BRAFV600E mutation in colorectal cancer: an updated meta-analysis
Der et al. Triple‐negative breast cancer in Ghanaian women: the Korle Bu teaching hospital experience
Schaefer et al. Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer
Van Wyk et al. The detection and role of lymphatic and blood vessel invasion in predicting survival in patients with node negative operable primary colorectal cancer
Trovik et al. The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma
Dawson et al. Optimizing the detection of venous invasion in colorectal cancer: the Ontario, Canada, experience and beyond
Freeny et al. Moving beyond morphology: new insights into the characterization and management of cystic pancreatic lesions
Thalgott et al. Detection of circulating tumor cells in locally advanced high-risk prostate cancer during neoadjuvant chemotherapy and radical prostatectomy
Ban et al. Follicular thyroid cancer: minimally invasive tumours can give rise to metastases
Wang et al. Utility of circulating free DNA fragmentomics in the prediction of pathological response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer
Manca et al. Sentinel lymph node mapping in melanoma: the issue of false-negative findings
Brönimann et al. An overview of current and emerging diagnostic, staging and prognostic markers for prostate cancer
Choi et al. Impact of lymph node dissection in radical cystectomy for bladder cancer: how many vs how far?
Sanlorenzo et al. Prognostic differences across sexes in melanoma patients: what has changed from the past?
He et al. Prognostic significance of lymphatic vessel invasion diagnosed by D2-40 in Chinese invasive breast cancers
Sari et al. Routine elastin staining in surgically resected colorectal cancer: impact on venous invasion detection and its association with oncologic outcomes
Vujic et al. Merkel cell carcinoma: mitoses, expression of Ki‐67 and bcl‐2 correlate with disease progression
Calhoun et al. Atypical apocrine adenosis diagnosed on breast core biopsy: implications for management
Moghaddam et al. Comparison of three mathematical models for predicting the risk of additional axillary nodal metastases after positive sentinel lymph node biopsy in early breast cancer